Next report date
Report period
Q1 2024
EPS estimate
1.99EUR
Revenue estimate
573.76 MEUR
−19.45EUR
−577.42 MEUR
2.42 BEUR
19.68 M
About Bio-Rad Laboratories, Inc.
Sector
Industry
CEO
Norman D. Schwartz
Website
Headquarters
Hercules
Employees (FY)
8.03 K
Founded
1952
FIGI
BBG000C08TR4
Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, and test kits. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange BIO-RAD LABORATORIES INC. stocks are traded under the ticker BUWA.
BIO-RAD LABORATORIES INC. is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.
BUWA earnings for the last quarter are 2.20 EUR per share, whereas the estimation was 2.63 EUR resulting in a −16.25% surprise. The estimated earnings for the next quarter are 2.55 EUR per share. See more details about BIO-RAD LABORATORIES INC. earnings.
BIO-RAD LABORATORIES INC. revenue for the last quarter amounts to 597.99 M EUR despite the estimated figure of 652.27 M EUR. In the next quarter revenue is expected to reach 620.61 M EUR.
Yes, you can track BIO-RAD LABORATORIES INC. financials in yearly and quarterly reports right on TradingView.
BUWA net income for the last quarter is 316.84 M EUR, while the quarter before that showed 100.52 M EUR of net income which accounts for 215.21% change. Track more BIO-RAD LABORATORIES INC. financial stats to get the full picture.
No, BUWA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, BUWA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIO-RAD LABORATORIES INC. stock right from TradingView charts — choose your broker and connect to your account.
BUWA reached its all-time high on Sep 13, 2021 with the price of 705.00 EUR, and its all-time low was 126.90 EUR and was reached on Aug 3, 2016. View more price dynamics on BUWA chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
As of May 2, 2024, the company has 8.03 K employees. See our rating of the largest employees — is BIO-RAD LABORATORIES INC. on this list?
We've gathered analysts' opinions on BIO-RAD LABORATORIES INC. future price: according to them, BUWA price has a max estimate of 410.64 EUR and a min estimate of 326.65 EUR. Watch BUWA chart and read a more detailed BIO-RAD LABORATORIES INC. stock forecast: see what analysts think of BIO-RAD LABORATORIES INC. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BIO-RAD LABORATORIES INC. EBITDA is 533.88 M EUR, and current EBITDA margin is 21.57%. See more stats in BIO-RAD LABORATORIES INC. financial statements.